Home

  • Home
    • » e-Newsletters

CMS issues three additional drug codes

Pharmacy Regulation Resource, April 22, 2004

The Centers for Medicare & Medicaid Services (CMS) issued pass-through codes in Transmittal 132, Change Request 3154 to three newly-approved drugs effective April 1. The codes are temporary until sufficient cost data exists to develop a reimbursement rate, according to CMS.

The three drugs include

  • daptomycin, an injectable antibiotic for staphylococcus infections, which CMS will reimburse at 31 cents for every 1 milligram administered (code C9124)
  • risperidone, an injectable antipsychotic, which CMS will reimburse at $131.86 for every 12.5 milligrams administered (code C9125)
  • rasburicase, an injectable for high uric acid levels resulting from certain cancer treatments, which CMS will reimburse at $105.54 for every .5 milligrams administered (code J2783)

Go to www.cms.hhs.gov/manuals/pm_trans/R132CP.pdfhttp://www.cms.hhs.gov/manuals/pm_trans/R132CP.pdf for the complete update.

Most Popular